WebIPS provides innovative digital solutions for document scanning, digital workflows, document archiving and process solutions. Contact us for a free consultation. WebFeb 12, 2024 · IPSS improvement 30-days postoperation was more pronounced in patients who received Mictalase®. Lower rate of positive urine culture favored Mictalase® group 15-days postoperatively. Trial registration. The clinical trial has been registered on ClinicalTrials.gov on November 23rd, 2024—Registration number NCT05130918. ...
Head-to-head comparison of prostatic urethral lift and water vapor …
WebDec 12, 2024 · Mean IPSS improvement at 1, 3, 6, and 12 months was at least 13.5 points and significantly better than baseline at every time point (Table 2, p < 0.0001). QoL and BPHII were similarly improved ... Webmonths. Individuals enrolled in both studies had a baseline IPSS of about 22. R ezūm and UroLift demonstrated similar IPSS improvement of 11.2 and 11.1, respectively, at three months, a decline of 50% compared to baseline. The improvements in IPSS-QoL were comparable. Patients treated with Rezūm had IPSS-QoL of 2.3 at three months from 4.4 henrico va personal property tax
Transurethral microwave thermotherapy: clinical results after 11 …
WebJan 18, 2024 · The improvement in QoL, Qmax, and IPSS over baseline are significant and while data over 2 years is sparse the treatment has remained durable thus far. Complications Complication profiles are paramount for any new procedure in the BPH induced LUTS space, as TURP is an excellent surgical option in terms of clinical … When assessing MIT outcomes, we typically look at International Prostate Symptom Score (IPSS) and IPSS-QoL, patient-reported satisfaction, and preservation of sexual function. Both Rezūm and UroLift significantly improve IPSS at three months. Individuals enrolled in both studies had a baseline IPSS of about … See more Durability of treatment is also of importance for MITs, as freedom from retreatment is important to patients. Five-year follow-up clinical data from the pivotal studies showed that Rezūm had lower surgical and … See more Annual treatment costs for BPH were estimated to be $4 billion in 2006.1 As a result, cost effectiveness of treatments is an important consideration. An analysis performed by Ulchaker et al. evaluated the cost effectiveness of … See more Rezūm and UroLift have demonstrated comparable improvement in IPSS, IPSS-QoL and Qmax. Both treatments score high on patient … See more It is important to set patient expectations prior to Rezūm Therapy. Because of the effect that steam has on tissue, most patients may require post-procedure catheterization for … See more WebAt 24 months, all groups demonstrated significant and sustained IPSS improvement. 2,3,6 An analysis of U.S. healthcare claims revealed higher de novo prescription rates after transurethral resection of the prostate (TURP) and photoselective vaporization of the prostate (PVP) compared to PUL. henricova.sharepoint